Scott JF, Gerstenblith MR. Melanoma of unknown primary. Noncutaneous melanoma. 2018 [cited 2023 May 7]; Available from: https://exonpublications.com/index.php/exon/issue/view/3

Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The american college of surgeons commission on cancer and the american cancer society. Cancer. 1998;83(8):1664–78.

Article  CAS  PubMed  Google Scholar 

Cancer Treatment & Survivorship Facts & Figures (2022–2024). 2022 [cited 2023 May 7]; Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/2022-cancer-treatment-and-survivorship-fandf-acs.pdf. Accessed 28 Feb 2023.

Mihajlovic M, et al. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739–53.

PubMed  PubMed Central  Google Scholar 

Hodi FS, et al. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol. 2013;31(26):3182–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuo JC. Immune checkpoint inhibitors in the treatment of advanced mucosal melanoma. Melanoma Manag. 2017;4(3):161–7.

Article  PubMed  PubMed Central  Google Scholar 

Shoushtari AN, et al. The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016;122(21):3354–62.

Article  CAS  PubMed  Google Scholar 

Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208–50.

Article  PubMed  Google Scholar 

NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Melanoma: cutaneous, version 1. 2023. [cited 2023 2/14]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf.

Party, A.C.N.M.G.R.W. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. 2008 [cited 2022 11/18]; Available from: https://www.health.govt.nz/system/files/documents/publications/melanoma-guideline-nov08-v2.pdf.

Michielin O, et al. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(12):1884–901.

Article  CAS  PubMed  Google Scholar 

Melanoma: assessment and management. 2022 [cited 2023 2/14]; Available from: https://www.nice.org.uk/guidance/ng14/chapter/Recommendations.

Garbe C, et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 2007;17(6):393–9.

Article  PubMed  Google Scholar 

Dummer R, et al. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2016;146: w14279.

PubMed  Google Scholar 

NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Melanoma: Uveal version 2. 2022. [cited 2023 2/14]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/uveal.pdf.

Nenclares P, et al. Head and neck mucosal melanoma: the United Kingdom national guidelines. Eur J Cancer. 2020;138:11–8.

Article  PubMed  Google Scholar 

Smith HG, et al. Ano-uro-genital mucosal melanoma UK national guidelines. Eur J Cancer. 2020;135:22–30.

Article  PubMed  Google Scholar 

NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Mucosal Melanoma of the head and neck version 1.2012. 2012 [cited 2023 2/14]; Available from: https://jnccn.org/downloadpdf/journals/jnccn/10/3/article-p320.xml.

NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Vulvar cancer version 1. 2023 [cited 2023 2/14]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/vulvar.pdf.

Vogel RI, et al. Sun exposure and protection behaviors among long-term melanoma survivors and population controls. Cancer Epidemiol Biomarkers Prev. 2017;26(4):607–13.

Article  PubMed  PubMed Central  Google Scholar 

Mujumdar UJ, et al. Sun protection and skin self-examination in melanoma survivors. Psychooncology. 2009;18(10):1106–15.

Article  PubMed  PubMed Central  Google Scholar 

Bowen D, et al. Skin care behaviors among melanoma survivors. Psychooncology. 2012;21(12):1285–91.

Article  PubMed  Google Scholar 

Halpern MT, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222–31.

Article  PubMed  Google Scholar 

Buster KJ, Stevens EI, Elmets CA. Dermatologic health disparities. Dermatol Clin. 2012;30(1):53–9 (viii).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roetzheim RG, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91(16):1409–15.

Article  CAS  PubMed  Google Scholar 

Smith JK, et al. Does increasing insurance improve outcomes for US cancer patients? J Surg Res. 2013;185(1):15–20.

Article  PubMed  Google Scholar 

Mattila K, et al. Smoking is an independent marker of poor prognosis in cutaneous melanoma. Acta Dermato-Venereol. 2023;103:adv00860.

Article  CAS  Google Scholar 

Jackson KM, et al. Smoking status and survival in patients with early-stage primary cutaneous melanoma. Jama Network Open. 2024;7(2):e2354751.

Article  PubMed  PubMed Central  Google Scholar 

Gritz ER, et al. Smoking behaviors in survivors of smoking-related and non-smoking-related cancers. JAMA Netw Open. 2020;3(7):e209072.

Article  PubMed  PubMed Central  Google Scholar 

Stenzel AE, et al. Cross-sectional study of physical activity among long-term melanoma survivors and population controls. Arch Dermatol Res. 2023;315(4):1011–6.

Article  PubMed  Google Scholar 

National Center fo Healt Statistics. Analytic and reporting guidelines. The National Health and Nutrition Examination Survey (NHANES). [cited 2023 May 7]. Available from: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Accessed 28 Feb 2023.

Fryar CD, et al. Trends in nutrient intakes and chronic health conditions among Mexican-American adults, a 25-year profile: United States, 1982–2006. Natl Health Stat Report. 2012;50:1–20.

Google Scholar 

Tseng TS, et al. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Survivorship-Res Pract. 2010;4(4):313–21.

Article  Google Scholar 

Fischer AH, et al. Sunburn and sun-protective behaviors among adults with and without previous nonmelanoma skin cancer (NMSC): a population-based study. J Am Acad Dermatol. 2016;75(2):371-379.e5.

Article  PubMed  PubMed Central  Google Scholar 

Lotz M, et al. Molecular subtype, biological sex and age shape melanoma tumour evolution. Br J Dermatol. 2021;184(2):328–37.

Article  CAS  PubMed  Google Scholar 

Ribero S, et al. Effect of age on melanoma risk, prognosis and treatment response. Acta Derm Venereol. 2018;98(7):624–9.

Article  CAS  PubMed  Google Scholar 

Lee PY, et al. Level of education and the risk of malignant melanoma. J Am Acad Dermatol. 1992;26(1):59–63.

Article  CAS  PubMed  Google Scholar 

Shao K, Hooper J, Feng H. Racial and ethnic health disparities in dermatology in the United States. Part 2: Disease-specific epidemiology, characteristics, management, and outcomes. J Am Acad Dermatol. 2022;87(4):733–44.

Article  PubMed  Google Scholar 

Jiang AJ, Rambhatla PV, Eide MJ. Socioeconomic and lifestyle factors and melanoma: a systematic review. Br J Dermatol. 2015;172(4):885–915.

Article  CAS  PubMed  Google Scholar 

Wang D, et al. Association between socioeconomic status and health behaviour change before and after non-communicable disease diagnoses: a multicohort study. Lancet Public Health. 2022;7(8):e670–82.

Article  PubMed  Google Scholar 

Hiscock R, et al. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248:107–23.

Article